ABSTRACT
Objetivo: Identificar a percepção dos pacientes sobre o significado de ser portador de glaucoma e a percepção que tem sobre o tratamento clínico ou cirúrgico. Métodos: Para a coleta dos dados utilizou-se a pesquisa qualitativa através da estratégia de grupos focais realizados com pacientes em tratamento clínico (grupo 1) e pacientes submetidos à cirurgia antiglaucomatosa (grupo 2). A análise e a interpretação dos resultados foram feitas pela técnica da análise de conteúdo. Resultados: O medo da cegueira e a desinformação sobre a doença foram os aspectos negativos mais encontrados com relação a ser portador de glaucoma. O grupo cirúrgico preferiu a situação atual quando comparada à necessidade do uso de medicação. Verificou-se que tanto o glaucoma quanto o seu tratamento impactaram profundamente esses pacientes e que, embora a preocupação com a doença ainda persista, os pacientes operados demonstraram apresentar menos impacto no seu cotidiano. Foram determinantes para a aceitação da indicação da cirurgia a falta de controle da doença e a confiança no médico, sendo esta última considerada um fator primordial nos dois grupos pesquisados, o que aponta para sua importância, independente da decisão tomada pelo paciente na convivência com sua doença. Conclusão: Identificaram-se os aspectos negativos mais relevantes com relação ao glaucoma e ao seu tratamento. A confiança na correta indicação do tipo de tratamento, clínico ou cirúrgico, e uma relação sólida entre o paciente e o médico são os fatores determinantes para uma maior tranquilidade dos pacientes em tratamento de glaucoma (clínico ou cirúrgico).
Objective: To identify the meaning and impact on their quality of life of having glaucoma and to understand the patients perception on the different types of treatment (medical or surgical). Methods: Through a qualitative research, focus groups were conducted with patients in clinical treatment (group 1) and patients who underwent glaucoma surgery in both eyes and were without medication (group 2). The responses were analyzed using the technique of content analysis. Results: Fear of blindness and lack of information about the disease were the most cited issues in relation to how it is like to having glaucoma. Medication costs, impact of drops on patients daily lives and the side effects were the main points discussed in relation to medical treatment. All patients in the surgical group preferred the current situation (without medication) when compared to the need for chronic use of medication. In the two groups, both glaucoma and its treatment had a profound impact on people, not only from a psychological standpoint, but also affecting their daily lives. Patients operated on for glaucoma appear to have less impact on their daily lives, but the concern about the disease persists. Conclusion: We identified the most significant negative aspects of glaucoma and its treatment from patients perspectives. Confidence in the correct indication of the type of treatment, clinical or surgical, and a solid relationship between the patient the doctor are determining factors for extra peace of mind of patients being treated for glaucoma.
Subject(s)
Humans , Male , Female , Middle Aged , Aged, 80 and over , Glaucoma, Open-Angle/surgery , Glaucoma, Open-Angle/psychology , Glaucoma, Open-Angle/drug therapy , Physician-Patient Relations , Quality of Life , Qualitative ResearchABSTRACT
Background Prostaglandin eye drops is front-line medicines of lowing intraocular pressure for primary open angle glaucoma (POAG),but its price is higher for long-term application.Domestic latanoprost drops has been applied in clinic.However,its trial of lowing intraocular pressure effect and safety from sizable sample and multi-center is lack.Objective This study was to observe the efficacy and safety of domestic latanoprost for POAG and ocular hypertension.Methods This prospective,multicenter trial was conducted at 25 hospitals in 5 territories of China,and 837 eyes of 576 patients with POAG and ocular hypertension were recruited in the hospitals based on the uniform criteria.Domestic latanoprost drops was topically used once per day at night for 3 months.Intraocular pressure (IOP) was measured 1 month and 2 months,3 months to assess the efficacy of drug,and vision acuity,blood pressure,pulse,ocular symptoms and signs were observed to evaluate the safety of the drug.This study approved by the Ethics Committee of Wuhan General Hospital of Guangzhou Military Command,and all patients were informed consent and signed informed consent.Results IOP was (28.36±7.86),(19.66±5.46),(19.59±7.86) and (19.35 ± 5.03) mmHg in pretreatment and posttreatment 1 month,2 months and 3 months,respectively,showing a significant difference among various time points (F =748.325,P =0.000),and the IOPs were markedly lower in posttreatment than those in pretreatment (all at P＜0.001).The falling range of IOP was (30.43 ±7.18)％,(30.19 ± 8.72)％,(30.71±9.90) ％ in posttreatment 1 month,2 months and 3 months,respectively.The efficiency was 95.70％,91.76％ and 88.05％ in 1 month,2 months and 3 months.Conjunctival hyperemia was observed in 13％ eyes at the end of following-up.No drug-related systemic and other ocular adverse reactions were found.Conclusions Domestic latanoprost drops can low IOP effectively without serious adverse reaction in POAG and ocular hypertensive patients.